Overtreatment of malaria in the Nigerian healthcare setting: prescription practice, rationale and consequences.


Journal

The Pan African medical journal
ISSN: 1937-8688
Titre abrégé: Pan Afr Med J
Pays: Uganda
ID NLM: 101517926

Informations de publication

Date de publication:
2023
Historique:
received: 28 09 2021
accepted: 08 06 2023
medline: 26 9 2023
pubmed: 25 9 2023
entrez: 25 9 2023
Statut: epublish

Résumé

Nigeria is one of the countries in the world with the highest burden of malaria, accounting for a quarter of all cases in Africa. According to the Centers for Disease Control and Prevention, microscopic examination remains the gold standard for laboratory confirmation of malaria. However, the policy and practice of presumptive treatment of malaria for all febrile illnesses has been widely advocated in sub-Saharan Africa. Presumptive management of fevers and/or other symptoms of malaria results in over-diagnosis, and consequently overtreatment. This article discusses the overtreatment of malaria as practiced in Nigeria and other African regions against standard treatment guidelines, highlights a wide range of its associated effects on patients and proffers possible solutions to curb the unethical practice of malaria overtreatment.

Identifiants

pubmed: 37745920
doi: 10.11604/pamj.2023.45.111.31780
pii: PAMJ-45-111
pmc: PMC10516759
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

111

Informations de copyright

Copyright: Emmanuel Temitope Anjorin et al.

Déclaration de conflit d'intérêts

The authors declare no competing interests.

Références

Niger Med J. 2015 Jul-Aug;56(4):278-82
pubmed: 26759514
Malar J. 2015 Mar 01;14:97
pubmed: 25890202
J Pharm Policy Pract. 2014 Nov 14;7(1):15
pubmed: 25838917
Cochrane Database Syst Rev. 2011 Jul 06;(7):CD008122
pubmed: 21735422
Malar J. 2008 Feb 18;7:33
pubmed: 18282270
Pan Afr Med J. 2011;10:29
pubmed: 22187611
J Infect Dev Ctries. 2013 Jan 15;7(1):51-9
pubmed: 23324821
Trop Med Int Health. 2002 Jan;7(1):45-52
pubmed: 11851954
PLoS One. 2014 Oct 21;9(10):e110361
pubmed: 25333909
Trop Med Int Health. 2005 Oct;10(10):1047-59
pubmed: 16185240
Niger Med J. 2014 Nov;55(6):480-5
pubmed: 25538366
Trop Med Int Health. 2015 Aug;20(8):1081-92
pubmed: 25877471
Int Med Case Rep J. 2019 Jul 09;12:213-216
pubmed: 31372061
Pan Afr Med J. 2020 Jan 14;35:11
pubmed: 32117526

Auteurs

Emmanuel Temitope Anjorin (ET)

Lagos State University Teaching Hospital (LASUTH), Ikeja, Lagos, Nigeria.

Olufemi Nicholas Olulaja (ON)

African Center of Excellence for Genomics of Infectious Diseases (ACEGID), Redeemer´s University, Ede, Osun State, Nigeria.

Moyosoore Emmanuel Osoba (ME)

African Center of Excellence for Genomics of Infectious Diseases (ACEGID), Redeemer´s University, Ede, Osun State, Nigeria.

Oluwafemi Temitayo Oyadiran (OT)

Medical Research Council Unit, London School of Hygiene and Tropical Medicine, Fajara, The Gambia.

Ayodele Oloruntoba Ogunsanya (AO)

Infectious Disease Hospital (Mainland Hospital), Yaba, Lagos State, Nigeria.

Omotola Nofisat Akinade (ON)

Ikorodu General Hospital, Ikorodu, Lagos, Nigeria.

Jemimah Mayowa Inuojo (JM)

Xcene Research (Contract Research Organization (CRO)), Ikeja, Lagos, Nigeria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH